#SenjuPharma has launched a new drug for #dryeyedisease (DED) in #Japan, #Avarept, which is the first drug in the #TRPV1antagonist class to reach the market.
0
0
0
0
#SenjuPharma has launched a new drug for #dryeyedisease (DED) in #Japan, #Avarept, which is the first drug in the #TRPV1antagonist class to reach the market.